• Home
  • Leadership
    • Management Team
    • Scientific Advisory Board
  • Therapeutic Programs
  • Media
  • Contact
GeneVentiv Announces Appointment to Scientific Advisory Board

GeneVentiv Announces Appointment to Scientific Advisory Board

by Damon Race | Jan 19, 2021 | Press

January 12, 2021 Damon R. Race, President & CEO RALEIGH, NC – GeneVentiv Therapeutics, a gene therapy company developing a safe, effective and durable, single infusion treatment for all types of hemophilia with or without inhibitors, today announced the...

Recent Posts

  • Bootstrapped UNC spinout lands $300K for gene therapy work
  • Triangle gene therapy startup GeneVentiv Therapeutics awarded $250K loan from NC Biotech Center
  • GeneVentiv Therapeutics Receives Funding from the North Carolina Biotechnology Center
  • GeneVentiv Therapeutics Wins KickStart Commercialization Grant
  • GeneVentiv Therapeutics selected to pitch at CED’s Venture Connect

Recent Comments

    Archives

    • June 2022
    • March 2022
    • February 2022
    • November 2021
    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020

    Categories

    • In the News
    • Press

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Contact Us

    • Please prove you are human by selecting the Tree.
    • This field is for validation purposes and should be left unchanged.

    Copyright © 2020 GeneVentiv Therapeutics. All rights reserved.